BiolineRX Announces Positive Results In Celiac Trial

By NoCamels Team · February 22, 2012 · No comments
News Flash ·

BioLineRx, a biopharmaceutical development company, announced the publication of pre-clinical results demonstrating that BL-7010, an orally available treatment for celiac disease, reduces gluten toxicity (the negative effect of gluten on the patient’s body). The research was published in the February edition of Gastroenterology. The findings indicate that BL-7010 (previously called P(HEMA-co-SS)) reduces digestion of wheat gluten, thereby decreasing its toxicity. View and share

Facebook comments:

‘Teva’ Launches Generic Drug Against Depression

March 15, 2012 ·

Teva Pharmaceutical Industries launched its generic version of Forest Laboratories’ Lexapro, for the treatment of depression and generalized anxiety disorder....

Report: ‘NDS’ To Be Sold For $5 Billion

March 15, 2012 ·

Computer communications giant Cisco Systems is in advanced talks to acquire NDS for $5 billion, Israeli website Calcalist reported. NDS,...

Microsoft Launches First Startup Accelerator In Israel

March 14, 2012 ·

Microsoft has launched the first startup accelerator in the company’s history, to encourage early-stage startups to build cloud-based applications using...